Cellectis S.A.
CLLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $143 | $137 | $90 | $186 |
| Short-Term Investments | $117 | $67 | $8 | $0 |
| Receivables | $23 | $23 | $18 | $31 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $6 | $29 | $8 |
| Total Curr. Assets | $287 | $233 | $144 | $225 |
| Property Plant & Equip (Net) | $76 | $93 | $108 | $148 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $1 | $2 |
| Long-Term Investments | $8 | $8 | $9 | $7 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $12 | -$0 | $0 | $0 |
| Total NC Assets | $96 | $101 | $117 | $157 |
| Other Assets | -$0 | -$0 | $0 | $0 |
| Total Assets | $384 | $334 | $261 | $382 |
| Liabilities | – | – | – | – |
| Payables | $19 | $19 | $21 | $24 |
| Short-Term Debt | $13 | $14 | $13 | $11 |
| Tax Payable | $0 | $0 | $3 | $0 |
| Deferred Revenue | $112 | $110 | $0 | $0 |
| Other Curr. Liab. | $22 | $12 | $26 | $15 |
| Total Curr. Liab. | $166 | $155 | $63 | $49 |
| LT Debt | $78 | $71 | $63 | $90 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $17 | $23 | $9 | $6 |
| Total NC Liab. | $95 | $94 | $72 | $96 |
| Other Liabilities | -$9 | $0 | $0 | $0 |
| Cap. Leases | $43 | $51 | $57 | $80 |
| Total Liabilities | $253 | $250 | $135 | $146 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $4 | $3 | $3 |
| Retained Earnings | -$330 | -$406 | -$440 | -$698 |
| AOCI | -$40 | -$37 | -$29 | -$18 |
| Other Equity | $494 | $523 | $583 | $935 |
| Total Equity | $131 | $85 | $118 | $221 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $8 | $15 |
| Total Liab. & Tot. Equity | $384 | $334 | $261 | $382 |
| Net Debt | -$52 | -$52 | -$14 | -$85 |